Literature DB >> 2619775

Simultaneous determination of the main metabolites of dipyrone by high-pressure liquid chromatography.

D Damm1.   

Abstract

A simple, rapid, and sensitive procedure is described for the determination of the main metabolites of dipyrone in plasma and urine. After adding isopropyl aminoantipyrine as internal standard and a deproteinizer the plasma of urine samples are alkalized and extracted with chloroform. The residue of the evaporated organic phase is dissolved in mobile phase and separated by HPLC. The compounds are detected by ultraviolet light at 265 nm. The following metabolites can be determined selectively by this method: 4-methylamino-antipyrine, 4-aminoantipyrine, 4-formylaminoantipyrine and 4-acetylaminoantipyrine. The detection limit for all four metabolites is 0.1 microgram/ml in plasma and 2 micrograms/ml in urine. The results of a human pharmacokinetic study are also presented.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2619775

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  7 in total

1.  The acetylation phenotype: does it contribute to the non-linearity of the metabolite pharmacokinetics of metamizol?

Authors:  N Bacracheva; V Vlahov
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  Inhibition of cyclooxygenases by dipyrone.

Authors:  S C Pierre; R Schmidt; C Brenneis; M Michaelis; G Geisslinger; K Scholich
Journal:  Br J Pharmacol       Date:  2007-04-16       Impact factor: 8.739

3.  Metamizole-furosemide interaction study in healthy volunteers.

Authors:  B Rosenkranz; K H Lehr; G Mackert; H W Seyberth
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics of dipyrone and its metabolites.

Authors:  M Levy; E Zylber-Katz; B Rosenkranz
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447

5.  Pharmacokinetics of metamizol metabolites in healthy subjects after a single oral dose of metamizol sodium.

Authors:  V Vlahov; M Badian; M Verho; N Bacracheva
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  99mTc sestamibi myocardial perfusion scintigraphy with the novel use of metamizol for the detection of perfusion reversibility.

Authors:  Eser Lay Ergün; Meltem Caglar; Murat Fani Bozkurt; Hakan Ergün
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-29       Impact factor: 9.236

7.  Fabrication of multiwalled carbon nanotube-surfactant modified sensor for the direct determination of toxic drug 4-aminoantipyrine.

Authors:  Jayant I Gowda; Arunkumar T Buddanavar; Sharanappa T Nandibewoor
Journal:  J Pharm Anal       Date:  2015-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.